How you can help shape the new National Cancer Plan
The Government is planning to reform the NHS in England, and as part of this, it is developing a new National Cancer Plan with the aim of improving cancer survival over the next decade. The National Cancer Plan will encompass the whole cancer pathway including prevention, early diagnosis, treatment, living with and beyond cancer, and research & development. The Department of Health and Social Care (DHSC) is asking for feedback to help shape the plan.
How is AMMF contributing to the National Cancer Plan?
AMMF is currently listening to the experiences and opinions of our community, while we develop a submission to this consultation. We conducted an online survey from the 19th to the 31st of March 2025 to collect views from people diagnosed with cholangiocarcinoma, their families, healthcare professionals and researchers. We are extremely grateful to the 88 people who participated. We will publish AMMF’s full submission on our website when it is finalised.
How you can contribute as an individual
The new National Cancer Plan for England is an important opportunity to encourage this Government to prioritise cholangiocarcinoma. Whilst AMMF is submitting a response, if lots of people from our community complete the DHSC survey, we will be harder to ignore.
Our top tips:
- Make sure you refer to cholangiocarcinoma and/or bile duct cancer by name throughout your response.
- Share what would have improved your or your loved one’s experience of NHS care.
- If it is relevant to your answers, please try to include some of the phrases below throughout the survey to help cholangiocarcinoma stand out:
“Early diagnosis of cholangiocarcinoma”
“Refer patients to expert cholangiocarcinoma consultants”
“Fair access to treatment and care for cholangiocarcinoma”
“More research into cholangiocarcinoma”
Please complete the survey by midnight on 29th April 2025
Thank you so much for completing the Government’s survey and using this opportunity to make sure cholangiocarcinoma is a priority for the NHS.